(NASDAQ: LNSR) Lensar's forecast annual revenue growth rate of 13.55% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 5.71%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.74%.
Lensar's revenue in 2026 is $60,079,000.On average, 5 Wall Street analysts forecast LNSR's revenue for 2026 to be $763,693,662, with the lowest LNSR revenue forecast at $722,901,371, and the highest LNSR revenue forecast at $796,482,403. On average, 5 Wall Street analysts forecast LNSR's revenue for 2027 to be $912,085,151, with the lowest LNSR revenue forecast at $819,288,220, and the highest LNSR revenue forecast at $1,048,206,988.
In 2028, LNSR is forecast to generate $1,186,295,903 in revenue, with the lowest revenue forecast at $1,024,110,275 and the highest revenue forecast at $1,345,112,908.